| scholarly article | Q13442814 |
| P50 | author | Dhananjay Pal | Q96247254 |
| P2093 | author name string | Ashim K Mitra | |
| Yi Hao | |||
| Xiaoyan Yang | |||
| Ravi Vaishya | |||
| Kishore Cholkar | |||
| Hoang M Trinh | |||
| Vibhuti Agrahari | |||
| Abhirup Mandal | |||
| Varun Khurana | |||
| Mary Joseph | |||
| Sujay Shah | |||
| Chandramouli Natarajan | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| The ancient Virus World and evolution of cells | Q21093198 | ||
| Involvement of caveolin-2 in caveolar biogenesis in MDCK cells | Q24297660 | ||
| Characterisation of the passive permeability barrier of nuclear pore complexes | Q24328870 | ||
| Recent advances in lymphatic targeted drug delivery system for tumor metastasis | Q27005580 | ||
| Adeno-associated virus-mediated cancer gene therapy: current status | Q27026177 | ||
| The clinical and functional significance of c-Met in breast cancer: a review | Q28081415 | ||
| Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles | Q28138819 | ||
| ABC Transporters: From Microorganisms to Man | Q28181688 | ||
| Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 | ||
| Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitors | Q28236180 | ||
| Toxic potential of materials at the nanolevel | Q28295314 | ||
| Mutational landscape and significance across 12 major cancer types | Q28300353 | ||
| Histamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidase | Q28392943 | ||
| Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer | Q28482911 | ||
| Magnetic nanoparticles as mediators of ligand-free activation of EGFR signaling | Q28534809 | ||
| Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases | Q28548580 | ||
| Ultrasound-enhanced drug delivery for cancer | Q29035807 | ||
| In vivo protein transduction: delivery of a biologically active protein into the mouse | Q29615482 | ||
| Mechanisms of cancer drug resistance | Q29615849 | ||
| Membrane transporters in drug development | Q29616802 | ||
| Cancer treatment and survivorship statistics, 2014 | Q29617702 | ||
| An Ultrasound Contrast Agent Targeted to P-Selectin Detects Activated Platelets at Supra-Arterial Shear Flow Conditions | Q30425444 | ||
| Targeted Gene Transfection from Microbubbles into Vascular Smooth Muscle Cells Using Focused, Ultrasound-Mediated Delivery | Q30430948 | ||
| Dual frequency method for simultaneous translation and real-time imaging of ultrasound contrast agents within large blood vessels | Q30434058 | ||
| Tumor vascular targeted delivery of polymer-conjugated adenovirus vector for cancer gene therapy | Q35238254 | ||
| Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy | Q35284618 | ||
| Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance. | Q35334366 | ||
| Screening and characterization of a novel RNA aptamer that specifically binds to human prostatic acid phosphatase and human prostate cancer cells | Q35543331 | ||
| A mRNA landscape of bovine embryos after standard and MAPK-inhibited culture conditions: a comparative analysis. | Q35608261 | ||
| Recent advances in nonviral vectors for gene delivery | Q35618915 | ||
| ABC transporter architecture and mechanism: implications from the crystal structures of BtuCD and BtuF. | Q35757366 | ||
| Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer | Q35793791 | ||
| Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B. | Q35800840 | ||
| Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors | Q35812239 | ||
| Cancer immunotherapy: a treatment for the masses | Q35833153 | ||
| Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial | Q35849547 | ||
| Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update | Q35904534 | ||
| Importin beta: conducting a much larger cellular symphony | Q35938681 | ||
| Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells | Q36010627 | ||
| In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles. | Q36058816 | ||
| Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. | Q36062352 | ||
| Multifunctional particles for melanoma-targeted drug delivery | Q36074733 | ||
| ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel | Q36121125 | ||
| Tumor-specific nuclear targeting: promises for anti-cancer therapy? | Q36452312 | ||
| A second-generation 2-Methoxyestradiol prodrug is effective against Barrett's adenocarcinoma in a mouse xenograft model | Q36509772 | ||
| Targeted delivery of paclitaxel to EphA2-expressing cancer cells | Q36511070 | ||
| Aptamers come of age - at last | Q36538095 | ||
| AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits Lewis lung carcinoma growth in mice | Q36642793 | ||
| Effect of charge, hydrophobicity, and sequence of nucleoporins on the translocation of model particles through the nuclear pore complex | Q36653861 | ||
| Mechanisms and insights into drug resistance in cancer | Q36682301 | ||
| Gene therapy progress and prospects: hydrodynamic gene delivery | Q36682676 | ||
| Influence of overexpression of efflux proteins on the function and gene expression of endogenous peptide transporters in MDR-transfected MDCKII cell lines | Q36744766 | ||
| Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics. | Q36760023 | ||
| Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging | Q36765663 | ||
| Synthesis and in vitro efficacy of MMP9-activated NanoDendrons | Q36775887 | ||
| Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors | Q36795709 | ||
| Host antitumour immune responses to HIFU ablation | Q36853082 | ||
| Synergistic inhibitory effect of high-intensity focused ultrasound combined with chemotherapy on Dunning adenocarcinoma | Q46407845 | ||
| Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release | Q46498027 | ||
| Mitochondrial-targeted prodrug cancer therapy using a rhodamine B labeled fluorinated docetaxel | Q46527226 | ||
| Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks | Q46601538 | ||
| Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model | Q46638866 | ||
| Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling | Q46742712 | ||
| Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells | Q46817260 | ||
| Ado-trastuzumab emtansine approved for advanced breast cancer | Q46845281 | ||
| Acid pH-activated glycol chitosan/fullerene nanogels for efficient tumor therapy | Q46931536 | ||
| Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size | Q47230491 | ||
| Ultrasound-induced cell membrane porosity | Q47664572 | ||
| Induction of apoptosis in vivo in the rabbit brain with focused ultrasound and Optison | Q48337630 | ||
| Increased infiltration of activated tumor-infiltrating lymphocytes after high intensity focused ultrasound ablation of human breast cancer | Q50248059 | ||
| Sonoporation mediated transduction of pDNA/siRNA into joint synovium in vivo. | Q50679500 | ||
| Ultrasound microbubble induced endothelial cell permeability. | Q50927827 | ||
| Ultrasound-mediated destruction of paclitaxel and oxygen loaded lipid microbubbles for combination therapy in ovarian cancer xenografts. | Q51000509 | ||
| Induced phenotype targeted therapy: radiation-induced apoptosis-targeted chemotherapy. | Q51025137 | ||
| A reusable magnetic graphene oxide-modified biosensor for vascular endothelial growth factor detection in cancer diagnosis. | Q51053553 | ||
| Oxidative quenching of quinone methide adducts reveals transient products of reversible alkylation in duplex DNA. | Q51076842 | ||
| An activatable theranostic for targeted cancer therapy and imaging. | Q51747526 | ||
| The prodrug platin-A: simultaneous release of cisplatin and aspirin. | Q51757111 | ||
| Postherpetic neuralgia: a workable treatment plan. | Q51801146 | ||
| LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. | Q51807114 | ||
| Short oligonucleotide prodrug having 5-fluoro and 5-iodouracil inhibits the proliferation of cancer cells in a photo-responsive manner. | Q53058177 | ||
| Substituent effects on oxidation-induced formation of quinone methides from arylboronic ester precursors. | Q53107301 | ||
| Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death. | Q53624957 | ||
| Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression. | Q53648839 | ||
| A dose-finding and pharmacokinetic study of reversal of multidrug resistance with SDZ PSC 833 in combination with doxorubicin in patients with solid tumors. | Q54116953 | ||
| N-Acyl-phosphoramidates as potential novel form of gemcitabine prodrugs. | Q54293128 | ||
| The promise of antibody-drug conjugates. | Q54472969 | ||
| Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs | Q57117289 | ||
| A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery | Q57273318 | ||
| Multifunctional squalene-based prodrug nanoparticles for targeted cancer therapy | Q57676482 | ||
| Research Spotlight: Applications of ultrasound for image-guided drug delivery in cancer chemotherapy | Q62565441 | ||
| Enhancement of the activity of immunotoxins by analogues of verapamil | Q69742341 | ||
| Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate | Q71848159 | ||
| Extracellular pH distribution in human tumours | Q72334607 | ||
| Preliminary investigations of ultrasound induced acoustic streaming using particle image velocimetry | Q73875813 | ||
| Ultrasound-facilitated transport of silver chloride (AgCl) particles in fish skin | Q74107784 | ||
| Heat-sensitive liposomes containing cisplatin and localized hyperthermia in treatment of murine tumor | Q77621526 | ||
| Cancer immunotherapy | Q80066933 | ||
| Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma | Q80206172 | ||
| Aptamer-functionalized magnetic nanoparticle-based bioassay for the detection of ochratoxin A using upconversion nanoparticles as labels | Q83820126 | ||
| Influence of ultrasound induced cavitation on magnetic resonance imaging contrast in the rat liver in the presence of macromolecular contrast agent | Q84020292 | ||
| Molecular targeted enhanced ultrasound imaging of flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model | Q84512825 | ||
| Brentuximab vedotin | Q85706779 | ||
| [Antibody-drug conjugates in oncology: from the concept to trastuzumab emtansine (T-DM1)] | Q85714525 | ||
| Designing a gold nanoparticle-based nanocarrier for microRNA transfection into the prostate and breast cancer cells | Q85832800 | ||
| A nitrophenyl-based prodrug type for colorectal targeting of prednisolone, budesonide and celecoxib | Q86138562 | ||
| Novel isoprenoyl nanoassembled prodrug for paclitaxel delivery | Q86545920 | ||
| Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin | Q86555025 | ||
| Novel cleavable cell-penetrating peptide-drug conjugates: synthesis and characterization | Q87543613 | ||
| Precise engineering of siRNA delivery vehicles to tumors using polyion complexes and gold nanoparticles | Q87607521 | ||
| Cell-penetrable lysine dendrimers for anti-cancer drug delivery: synthesis and preliminary biological evaluation | Q87698817 | ||
| Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies | Q87841796 | ||
| Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis | Q30438396 | ||
| Microbubbles in ultrasound-triggered drug and gene delivery | Q30438994 | ||
| Overview of therapeutic ultrasound applications and safety considerations | Q30447970 | ||
| Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment | Q30454718 | ||
| Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions | Q30465710 | ||
| Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging | Q30477363 | ||
| Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles | Q30479575 | ||
| ECHOGENIC LIPSOMES FOR TARGETED DRUG DELIVERY. | Q30480915 | ||
| Driving delivery vehicles with ultrasound | Q30483826 | ||
| In vivo effects of cavitation alone or in combination with chemotherapy in a peritoneal carcinomatosis in the rat. | Q30486862 | ||
| Progress and problems in the application of focused ultrasound for blood-brain barrier disruption | Q30487878 | ||
| Ultrasound mediated delivery of drugs and genes to solid tumors | Q30488681 | ||
| Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption | Q30489416 | ||
| Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. | Q30493238 | ||
| Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles | Q30499622 | ||
| Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy | Q30501162 | ||
| Investigation of HIFU-induced anti-tumor immunity in a murine tumor model | Q30502120 | ||
| Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine | Q30582495 | ||
| Disulfide cross-linked phosphorylcholine micelles for triggered release of camptothecin | Q30641959 | ||
| Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity | Q30712774 | ||
| CD44-targeted docetaxel conjugate for cancer cells and cancer stem-like cells: a novel hyaluronic acid-based drug delivery system | Q30738016 | ||
| pH and hydrogen peroxide dual responsive supramolecular prodrug system for controlled release of bioactive molecules | Q30834427 | ||
| Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy | Q30955663 | ||
| Ultrasound-enhanced drug delivery in prostate cancer xenografts by nanoparticles stabilizing microbubbles | Q31161580 | ||
| Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic | Q31923033 | ||
| Aptamers: an emerging class of therapeutics | Q33211036 | ||
| Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers | Q33235069 | ||
| A DNA transporter based on mesoporous silica nanospheres mediated with polycation poly(allylamine hydrochloride) coating on mesopore surface | Q33338346 | ||
| A Phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy | Q33360952 | ||
| Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study | Q33401346 | ||
| Gene medicine for cancer treatment: commercially available medicine and accumulated clinical data in China | Q33516121 | ||
| Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia | Q33561078 | ||
| Tumor heterogeneity: causes and consequences | Q33624298 | ||
| Increased delivery of doxorubicin into tumor cells using extracellularly activated TAT functionalized liposomes: in vitro and in vivo study. | Q38976009 | ||
| Synthesis and inclusion study of a novel γ-cyclodextrin derivative as a potential thermo-sensitive carrier for doxorubicin. | Q38978573 | ||
| Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy | Q38991978 | ||
| Design of a paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cells | Q38993094 | ||
| Preparation, optimization and in vitro characterization of stearoyl-gemcitabine polymeric micelles: a comparison with its self-assembled nanoparticles | Q39004327 | ||
| 13F-1, a novel 5-fluorouracil prodrug containing an Asn-Gly-Arg (NO2) COOCH3 tripeptide, inhibits human colonic carcinoma growth by targeting Aminopeptidase N (APN/CD13). | Q39004875 | ||
| Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells. | Q39014066 | ||
| Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo | Q39025502 | ||
| Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development. | Q39029664 | ||
| Synthesis and optimization of a bifunctional hyaluronan-based camptothecin prodrug | Q39036296 | ||
| Co-delivery of small interfering RNA using a camptothecin prodrug as the carrier | Q39042837 | ||
| Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy. | Q39043200 | ||
| Near-infrared light-mediated photoactivation of a platinum antitumor prodrug and simultaneous cellular apoptosis imaging by upconversion-luminescent nanoparticles. | Q39047691 | ||
| Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome-microbubble complexes assisted by ultrasound | Q39052614 | ||
| Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte-macrophage colony-stimulating factor for murine ovarian cancer | Q39058604 | ||
| Targeted polysaccharide nanoparticle for adamplatin prodrug delivery | Q39061436 | ||
| Selective cancer targeting with prodrugs activated by histone deacetylases and a tumour-associated protease | Q39066800 | ||
| Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery | Q39077133 | ||
| Tailored doxorubicin-hyaluronan conjugate as a potent anticancer glyco-drug: an alternative to prodrug approach | Q39077970 | ||
| Active targeting of block copolymer micelles with trastuzumab Fab fragments and nuclear localization signal leads to increased tumor uptake and nuclear localization in HER2-overexpressing xenografts | Q39091930 | ||
| Aptamer-conjugated Mn3O4@SiO2 core-shell nanoprobes for targeted magnetic resonance imaging | Q39093063 | ||
| Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment. | Q39095964 | ||
| Novel peptide-doxorubucin conjugates for targeting breast cancer cells including the multidrug resistant cells | Q39096797 | ||
| Lipophilic prodrugs of a triazole-containing colchicine analogue in liposomes: biological effects on human tumor cells | Q39102678 | ||
| Cell uptake enhancement of folate targeted polymer coated magnetic nanoparticles | Q39125334 | ||
| Self-assemblies of pH-activatable PEGylated multiarm poly(lactic acid-co-glycolic acid)-doxorubicin prodrugs with improved long-term antitumor efficacies | Q39125982 | ||
| Synthesis and in vitro cytostatic activity of 1,2- and 1,3-diacylglycerophosphates of clofarabine | Q39131492 | ||
| Acyloxymethyl esters of isophosphoramide mustard as new anticancer prodrugs | Q39140737 | ||
| Knockdown of protein phosphatase magnesium-dependent 1 (PPM1D) through lentivirus-mediated RNA silencing inhibits colorectal carcinoma cell proliferation | Q39142682 | ||
| Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy. | Q39143452 | ||
| Novel epithelial cell adhesion molecule antibody conjugated polyethyleneimine-capped gold nanoparticles for enhanced and targeted small interfering RNA delivery to retinoblastoma cells | Q39149758 | ||
| Biological properties of melanoma and endothelial cells after plasmid AMEP gene electrotransfer depend on integrin quantity on cells. | Q39155558 | ||
| Synthesis and biological evaluation of fluoro analogues of antimitotic phenstatin | Q39160451 | ||
| Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field | Q33625192 | ||
| HER2/neu Antibody Conjugated Poly(amino acid)-Coated Iron Oxide Nanoparticles for Breast Cancer MR Imaging | Q33713063 | ||
| Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery. | Q33734954 | ||
| Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection | Q33795417 | ||
| Purification, synthesis and characterization of AaCtx, the first chlorotoxin-like peptide from Androctonus australis scorpion venom. | Q33801818 | ||
| An optical and microPET assessment of thermally-sensitive liposome biodistribution in the Met-1 tumor model: Importance of formulation | Q33818246 | ||
| Causes and consequences of tumour acidity and implications for treatment | Q33818730 | ||
| Pt(IV) prodrugs designed to bind non-covalently to human serum albumin for drug delivery | Q33825880 | ||
| Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer | Q33862861 | ||
| Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. | Q33896810 | ||
| The nuclear pore complex: a protein machine bridging the nucleus and cytoplasm | Q33912881 | ||
| Trastuzumab-conjugated liposome-coated fluorescent magnetic nanoparticles to target breast cancer | Q33929273 | ||
| Kinetic analysis of translocation through nuclear pore complexes | Q33938174 | ||
| Adeno-associated virus type 2 infection of nude mouse human breast cancer xenograft induces necrotic death and inhibits tumor growth | Q33989913 | ||
| Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound | Q34003611 | ||
| Adenoviral vector-mediated gene therapy for gliomas: coming of age. | Q34022048 | ||
| Reactive oxygen species (ROS) inducible DNA cross-linking agents and their effect on cancer cells and normal lymphocytes | Q34049655 | ||
| Conjugates of cisplatin and cyclooxygenase inhibitors as potent antitumor agents overcoming cisplatin resistance. | Q34060461 | ||
| Toward hypoxia-selective DNA-alkylating agents built by grafting nitrogen mustards onto the bioreductively activated, hypoxia-selective DNA-oxidizing agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine). | Q34061361 | ||
| Contrast agents for MR imaging of the liver | Q34127781 | ||
| PPM1D silencing by RNA interference inhibits the proliferation of lung cancer cells | Q34136105 | ||
| Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery | Q34174125 | ||
| P-glycoprotein: from genomics to mechanism. | Q34272173 | ||
| NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis. | Q34324711 | ||
| The novel alkylating prodrug melflufen (J1) inhibits angiogenesis in vitro and in vivo | Q34363166 | ||
| Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma. | Q34413695 | ||
| Non-viral vectors for gene-based therapy | Q34429032 | ||
| Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. | Q34447986 | ||
| Multifunctional core/shell nanoparticles cross-linked polyetherimide-folic acid as efficient Notch-1 siRNA carrier for targeted killing of breast cancer | Q34519604 | ||
| A DNA aptamer with high affinity and specificity for molecular recognition and targeting therapy of gastric cancer | Q34565529 | ||
| Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity | Q34566961 | ||
| Targeting PPM1D by lentivirus-mediated RNA interference inhibits the tumorigenicity of bladder cancer cells | Q34574266 | ||
| Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides. | Q34604822 | ||
| pH-triggered intracellular release from actively targeting polymer micelles | Q34627898 | ||
| Understanding and targeting cancer stem cells: therapeutic implications and challenges | Q36907405 | ||
| Efficacious cyclic N-acyl O-amino phenol duocarmycin prodrugs | Q36943532 | ||
| Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance | Q37016869 | ||
| Development and application of a dual-purpose nanoparticle platform for delivery and imaging of siRNA in tumors | Q37081569 | ||
| Factors affecting the clearance and biodistribution of polymeric nanoparticles. | Q37146591 | ||
| Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study | Q37153412 | ||
| Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity. | Q37174354 | ||
| Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots | Q37214403 | ||
| In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. | Q37216626 | ||
| Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis | Q37254863 | ||
| Development of a tumor-specific photoactivatable doxorubicin prodrug | Q37280632 | ||
| Monofunctional and higher-valent platinum anticancer agents. | Q37282213 | ||
| Novel membrane-permeable contrast agent for brain tumor detection by MRI | Q37284164 | ||
| CRM1-mediated nuclear export of proteins and drug resistance in cancer | Q37320237 | ||
| AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer. | Q37374843 | ||
| Ultrasound triggered image-guided drug delivery | Q37409835 | ||
| Peptide-mediated DNA condensation for non-viral gene therapy. | Q37430562 | ||
| Molecular therapeutics of cancer by means of electroporation-based transfer of siRNAs and EBV-based expression vectors | Q37501982 | ||
| New strategies for cancer gene therapy: progress and opportunities | Q37577964 | ||
| Hyaluronidase-sensitive nanoparticle templates for triggered release of HIV/AIDS microbicide in vitro | Q37601061 | ||
| Experimental strategies in gene therapy of cancer. | Q37604243 | ||
| The leaving group strongly affects H₂O₂-induced DNA cross-linking by arylboronates | Q37612273 | ||
| Adenovirus-mediated cancer gene therapy and virotherapy (Review). | Q37643498 | ||
| Emerging applications of stimuli-responsive polymer materials | Q37679697 | ||
| Silicate esters of paclitaxel and docetaxel: synthesis, hydrophobicity, hydrolytic stability, cytotoxicity, and prodrug potential | Q37697357 | ||
| Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity | Q37699783 | ||
| Far-red light activatable, multifunctional prodrug for fluorescence optical imaging and combinational treatment | Q37727672 | ||
| Remotely triggerable drug delivery systems | Q37785501 | ||
| Engineering nanocomposite materials for cancer therapy | Q37794066 | ||
| Hydrodynamic gene delivery and its applications in pharmaceutical research | Q37824615 | ||
| Synergistic effect of ultrasound and antibiotics against Chlamydia trachomatis-infected human epithelial cells in vitro | Q37852485 | ||
| Nuclear drug delivery for cancer chemotherapy. | Q37918608 | ||
| Enzyme-responsive nanoparticles for drug release and diagnostics. | Q37977773 | ||
| Transformation-induced mutations in transgenic plants: analysis and biosafety implications | Q38005167 | ||
| Plasmid IL-12 electroporation in melanoma. | Q38059773 | ||
| Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma | Q34887442 | ||
| Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy | Q35029953 | ||
| Oligonucleotides--assembled Au nanorod-assisted cancer photothermal ablation and combination chemotherapy with targeted dual-drug delivery of Doxorubicin and Cisplatin prodrug | Q35100212 | ||
| Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer | Q35131992 | ||
| Free radical formation induced by ultrasound and its biological implications | Q35232001 | ||
| Targeted delivery of doxorubicin into tumor cells via MMP-sensitive PEG hydrogel-coated magnetic iron oxide nanoparticles (MIONPs). | Q35237180 | ||
| Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors | Q44867437 | ||
| Macromolecular prodrug that provides the irinotecan (CPT-11) active-metabolite SN-38 with ultralong half-life, low C(max), and low glucuronide formation. | Q44913074 | ||
| Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies | Q44991784 | ||
| Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. | Q45019846 | ||
| A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen | Q45125373 | ||
| Recombinant adeno-associated virus encoding Epstein-Barr virus latent membrane proteins fused with heat shock protein as a potential vaccine for nasopharyngeal carcinoma | Q45144516 | ||
| Sonophoresis. II. Examination of the mechanism(s) of ultrasound-enhanced transdermal drug delivery | Q45163090 | ||
| Targeting of nanoparticles to the clathrin-mediated endocytic pathway | Q45864648 | ||
| High-efficiency transfection of nucleic acids by the modified calcium phosphate precipitation method in chondrocytes | Q45879695 | ||
| Systemic administration of a PEGylated adenovirus vector with a cancer-specific promoter is effective in a mouse model of metastasis | Q45887307 | ||
| Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. | Q45930564 | ||
| Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. | Q45940724 | ||
| Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients. | Q46014412 | ||
| Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation | Q46147948 | ||
| A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia. | Q46183389 | ||
| Preparation and characterization of novel poly(ethylene glycol) paclitaxel derivatives | Q46187223 | ||
| Recent advances in design of immunogenic and effective naked DNA vaccines against cancer | Q38085021 | ||
| Aptamers: molecules of great potential | Q38103145 | ||
| Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives. | Q38108658 | ||
| Ultrasound-mediated drug/gene delivery in solid tumor treatment | Q38115401 | ||
| Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes | Q38119518 | ||
| Applications of cell-penetrating peptides for tumor targeting and future cancer therapies. | Q38166533 | ||
| Gene therapy and DNA delivery systems | Q38167136 | ||
| pH-sensitive nano-systems for drug delivery in cancer therapy | Q38169030 | ||
| Orchestrating immune check-point blockade for cancer immunotherapy in combinations | Q38184138 | ||
| Electroporation-based technologies for medicine: principles, applications, and challenges. | Q38218252 | ||
| Biosynthesis and the conjugation of magnetite nanoparticles with luteinizing hormone releasing hormone (LHRH). | Q38285894 | ||
| Identification of liver cancer-specific aptamers using whole live cells | Q38294792 | ||
| MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma. | Q38299859 | ||
| Targeted and ultrasound-triggered drug delivery using liposomes co-modified with cancer cell-targeting aptamers and a thermosensitive polymer. | Q38309779 | ||
| Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts. | Q38315077 | ||
| The Pharmacokinetics of Cell-Penetrating Peptides | Q38340819 | ||
| Aptamer nanomedicine for cancer therapeutics: barriers and potential for translation. | Q38366753 | ||
| Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT. | Q38425500 | ||
| Targeting the Bone Microenvironment in Metastatic Castration-Resistant Prostate Cancer | Q38429067 | ||
| Multifunctional magnetic nanoparticles modified with polyethylenimine and folic acid for biomedical theranostics | Q38450638 | ||
| Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging | Q38874446 | ||
| miRNA-221 and miRNA-222 induce apoptosis via the KIT/AKT signalling pathway in gastrointestinal stromal tumours | Q38883917 | ||
| Versican silencing improves the antitumor efficacy of endostatin by alleviating its induced inflammatory and immunosuppressive changes in the tumor microenvironment | Q38887374 | ||
| Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly(lactic-co-glycolic acid) nanoparticles | Q38889403 | ||
| Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI. | Q38914039 | ||
| Preactivated oxazaphosphorines designed for isophosphoramide mustard delivery as bulk form or nanoassemblies: synthesis and proof of concept. | Q38930156 | ||
| Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16. | Q38932275 | ||
| Highly effective inhibition of lung cancer growth and metastasis by systemic delivery of siRNA via multimodal mesoporous silica-based nanocarrier | Q38951009 | ||
| Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be? | Q38961699 | ||
| Annexin A2 is implicated in multi-drug-resistance in gastric cancer through p38MAPK and AKT pathway | Q38963460 | ||
| Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands. | Q38971493 | ||
| ZEB1 knockdown mediated using polypeptide cationic micelles inhibits metastasis and effects sensitization to a chemotherapeutic drug for cancer therapy | Q38974682 | ||
| Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. | Q39195635 | ||
| Poly(ethylene glycol) shell-sheddable nanomicelle prodrug of camptothecin with enhanced cellular uptake. | Q39199024 | ||
| Mechanistic study of the covalent loading of paclitaxel via disulfide linkers for controlled drug release. | Q39223714 | ||
| Improving the antitumor activity of squalenoyl-paclitaxel conjugate nanoassemblies by manipulating the linker between paclitaxel and squalene | Q39232076 | ||
| Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models | Q39247534 | ||
| Camptothecin-7-yl-methanthiole: semisynthesis and biological evaluation | Q39255471 | ||
| A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo | Q39264284 | ||
| Targeted lipid based drug conjugates: a novel strategy for drug delivery. | Q39332407 | ||
| CO2 gas induced drug release from pH-sensitive liposome to circumvent doxorubicin resistant cells | Q39365167 | ||
| Enhanced anti-glioblastoma activity of microglia by AAV2-mediated IL-12 through TRAIL and phagocytosis in vitro | Q39576819 | ||
| Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties and in vivo behavior | Q39624333 | ||
| Influence of extracellular pH on the cytotoxicity, cellular accumulation, and DNA interaction of novel pH-sensitive 2-aminoalcoholatoplatinum(II) complexes | Q39625764 | ||
| Efficient nuclear drug translocation and improved drug efficacy mediated by acidity-responsive boronate-linked dextran/cholesterol nanoassembly | Q39631068 | ||
| Evaluation of the temporal window for drug delivery following ultrasound-mediated membrane permeability enhancement | Q39697051 | ||
| Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative | Q39709772 | ||
| Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide. | Q39740554 | ||
| DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery | Q39746063 | ||
| Mediating tumor targeting efficiency of nanoparticles through design | Q39864411 | ||
| Preparation of hierarchical hollow CaCO3 particles and the application as anticancer drug carrier | Q39922079 | ||
| Efficient gene delivery using reconstituted chromatin enhanced for nuclear targeting. | Q40000002 | ||
| Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo | Q40023784 | ||
| Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells | Q40026176 | ||
| Targeted charge-reversal nanoparticles for nuclear drug delivery | Q40127866 | ||
| Targeting gene therapy for prostate cancer cells by liposomes complexed with anti-prostate-specific membrane antigen monoclonal antibody | Q40221738 | ||
| Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors | Q40269728 | ||
| Clinical safety of induced CTL infusion through recombinant adeno-associated virus-transfected dendritic cell vaccination in Chinese cancer patients | Q40278871 | ||
| "Intelligent" polymers in medicine and biotechnology. | Q40454589 | ||
| MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors. | Q40464073 | ||
| Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues | Q40533503 | ||
| Isolation and mapping of a polymorphic DNA sequence (pCMM8.1) on chromosome 1p [D1S63] | Q40556209 | ||
| Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. | Q40609513 | ||
| Targeted drug delivery to tumors: myths, reality and possibility | Q40868797 | ||
| Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells | Q40994215 | ||
| UV-Induced DNA Interstrand Cross-Linking and Direct Strand Breaks from a New Type of Binitroimidazole Analogue | Q41112734 | ||
| Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. | Q41167886 | ||
| Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients | Q41328786 | ||
| Tumor-targeted Chlorotoxin-coupled Nanoparticles for Nucleic Acid Delivery to Glioblastoma Cells: A Promising System for Glioblastoma Treatment. | Q41459815 | ||
| In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. | Q41522468 | ||
| Gene electrotransfer clinical trials | Q41522827 | ||
| SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma | Q41591996 | ||
| Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia | Q41613500 | ||
| Development of Novel Magnetic Nanoparticles for Hyperthermia Cancer Therapy | Q41821934 | ||
| Conjugation of Monoclonal Antibodies to Super Paramagnetic Iron Oxide Nanoparticles for Detection of her2/neu Antigen on Breast Cancer Cell Lines. | Q42084798 | ||
| Phase I and pharmacokinetic study of the multidrug resistance modulator dexverapamil with EPOCH chemotherapy | Q42277372 | ||
| Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union | Q42516930 | ||
| Oxidative halogenation of cisplatin and carboplatin: synthesis, spectroscopy, and crystal and molecular structures of Pt(IV) prodrugs | Q43051494 | ||
| A core cross-linked polymeric micellar platium(IV) prodrug with enhanced anticancer efficiency | Q43411545 | ||
| A facile approach for dual-responsive prodrug nanogels based on dendritic polyglycerols with minimal leaching | Q43519220 | ||
| Synthesis and activity of a folate targeted monodisperse PEG camptothecin conjugate | Q43534141 | ||
| An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer | Q43653289 | ||
| Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan: muscle biopsy findings in 4 patients | Q43797167 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 248-268 | |
| P577 | publication date | 2015-10-06 | |
| P1433 | published in | Journal of Controlled Release | Q6295046 |
| P1476 | title | Novel delivery approaches for cancer therapeutics. | |
| P478 | volume | 219 |
| Q38838668 | Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology. |
| Q33914097 | Arginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency |
| Q50085294 | Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity |
| Q93104741 | Co-Delivery of Eugenol and Dacarbazine by Hyaluronic Acid-Coated Liposomes for Targeted Inhibition of Survivin in Treatment of Resistant Metastatic Melanoma |
| Q58139962 | Electron microscopy for inorganic-type drug delivery nanocarriers for antitumoral applications: what does it reveal? |
| Q47864891 | Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs |
| Q64261641 | Glioblastoma Stem Cells and Comparison of Isolation Methods |
| Q48902538 | How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches |
| Q35945913 | Identification of a Short Cell-Penetrating Peptide from Bovine Lactoferricin for Intracellular Delivery of DNA in Human A549 Cells |
| Q89849951 | Increased Temperature Facilitates Adeno-Associated Virus Vector Transduction of Colorectal Cancer Cell Lines in a Manner Dependent on Heat Shock Protein Signature |
| Q60959844 | Magnetic Drug Delivery: Where the Field Is Going |
| Q42859704 | Metal-Organic Polyhedron Capped with Cucurbit[8]uril Delivers Doxorubicin to Cancer Cells |
| Q39433258 | Molecular approaches to potentiate cisplatin responsiveness in carcinoma therapeutics |
| Q47139128 | Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly |
| Q92066362 | Preparation and Evaluation of A Novel Liposomal Nano-Formulation in Metastatic Cancer Treatment Studies |
| Q40235588 | Prolonged circulation and increased tumor accumulation of liposomal vincristine in a mouse model of rhabdomyosarcoma |
| Q47199024 | Structure optimization to improve the delivery efficiency and cell selectivity of a tumor-targeting cell-penetrating peptide |
| Q28066254 | The potential for tumor suppressor gene therapy in head and neck cancer |
| Q38905979 | Transporter effects on cell permeability in drug delivery |
| Q52318550 | Tumor progression: the neuronal input. |
| Q99551899 | Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review) |
Search more.